Compare Bath & Body Works Inc (BBWI) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bath & Body Works Inc vs Marsh & McLennan Companies, Inc. — how do they compare? Bath & Body Works Inc trades at $18.21 (market cap $3.81B), while Marsh & McLennan Companies, Inc. trades at $188.94 (market cap $91.27B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 24× Bath & Body Works Inc's market cap, and Bath & Body Works Inc pays the higher dividend (4.24%). Which is the better fit depends on your goals.
| BBWI | MRSH | |
|---|---|---|
Market Cap | $3.81B | $91.27B |
Sector | Consumer Cyclical | Financials |
52-Week High | $31.87 | $211.21 |
52-Week Low | $14.85 | $157.32 |
Enterprise Value | $7.70B | $111.95B |
Dividend Yield | 4.24% | 2.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BBWI trades at $18.48, down 4.35% today, reflecting bearish technical signals but attractive valuations with a P/E of 5.36 and P/S of 0.54. Recent earnings show mixed results, with Q1 2026 beating estimates, while revenue has declined over five years. The company maintains strong gross margins above 43% and positive cash flow, supported by strategic expansions into Brazil and a partnership with Ulta Beauty announced in June 2026.
The stock presents a value opportunity given low multiples and analyst consensus price target of $22.11, though risks include persistent revenue declines, high debt levels, and negative shareholder equity. Investor sentiment is cautiously optimistic amid turnaround efforts, but technical weakness suggests near-term pressure.
Marsh & McLennan (MRSH) trades at $189.13, down 0.87% on the day, with a bullish technical signal and strong fundamental performance. Recent earnings beats in Q2 2026, with EPS of $2.96 versus $2.88 expected, and 6% revenue growth highlight operational strength. The company announced the acquisition of Accel to expand its Midwest insurance reach, signaling strategic growth. Valuation metrics show a P/E of 23.35 and robust profitability with a net income margin of 14.24%.
The outlook remains positive with a consensus price target of $202.89, offering potential upside. Risks include margin pressure from rising expenses and soft P&C pricing. Institutional activity is mixed, with Bank of America reducing its stake while others like Bank of Nova Scotia increased holdings. The stock presents a solid long-term growth opportunity amid cyclical insurance sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bath & Body Works Inc
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →
